Atherosclerosis: Open Access
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Rapid Communication   
  • Atheroscler Open Access 9: 290,
  • DOI: 10.4172/asoa.1000290

Therapeutic Targeting of Angiogenesis in Atherosclerosis: Challenges and Future Directions

Peter Wang*
Department of medical Science of biology, University of Science and Technology, Bhutan
*Corresponding Author : Peter Wang, Department of medical Science of biology, University of Science and Technology, Bhutan, Email: peterw@gmail.co.edu

Received Date: Nov 02, 2024 / Published Date: Nov 29, 2024

Citation: Peter W (2024) Therapeutic Targeting of Angiogenesis in Atherosclerosis:Challenges and Future Directions. Atheroscler Open Access 9: 290. Doi: 10.4172/asoa.1000290

Copyright: © 2024 Peter W. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top